Renal denervation trial 'flawed'

The effectiveness of renal denervation has been called into question ever since the SYMPLICITY HTN-3 trial was halted due to lack of efficacy, despite early open-label registry trials showing the procedure had significant and durable reductions in blood pressure in certain patients with resistant hypertension.